These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 7915370

  • 1. Lipid profiles on fibric-acid derivatives.
    Capps NE.
    Lancet; 1994 Sep 03; 344(8923):684-5. PubMed ID: 7915370
    [No Abstract] [Full Text] [Related]

  • 2. Abnormal lipid profiles on fibrate derivatives.
    McLeod AJ, Warren RJ, Armitage M.
    Lancet; 1996 Jan 27; 347(8996):261. PubMed ID: 8551900
    [No Abstract] [Full Text] [Related]

  • 3. Ciprofibrate and lipid profile.
    Chandler HA, Batchelor AJ.
    Lancet; 1994 Jul 09; 344(8915):128-9. PubMed ID: 7912363
    [No Abstract] [Full Text] [Related]

  • 4. Impressive lipid changes following hypolipidaemic drug administration can unveil subclinical hyperthyroidism.
    Liberopoulos E, Miltiadous G, Elisaf M.
    Diabetes Obes Metab; 2001 Apr 09; 3(2):97-8. PubMed ID: 11298731
    [Abstract] [Full Text] [Related]

  • 5. [The treatment of chronic ischemic heart disease: the potentials for hypolipidemic correction using current drugs].
    Tashchuk VK, Makoviĭchuk IO, Bilets'kyĭ SV, Hrechko SI, Polishchuk OIu, Turubarova NA.
    Lik Sprava; 1998 Apr 09; (5):101-3. PubMed ID: 9793321
    [Abstract] [Full Text] [Related]

  • 6. Statin + fibrate combination therapy fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular disease.
    Papadakis JA, Ganotakis ES, Jagroop IA, Winder AF, Mikhailidis DP.
    Int J Cardiol; 1999 Jun 01; 69(3):237-44. PubMed ID: 10402106
    [Abstract] [Full Text] [Related]

  • 7. Comparative efficacy and safety of ciprofibrate and sustained-release bezafibrate in patients with type II hyperlipidaemia.
    Betteridge DJ, O'Bryan-Tear CG.
    Postgrad Med J; 1996 Dec 01; 72(854):739-43. PubMed ID: 9015467
    [Abstract] [Full Text] [Related]

  • 8. Drug interactions with fibric acids.
    Lozada A, Dujovne CA.
    Pharmacol Ther; 1994 Aug 01; 63(2):163-76. PubMed ID: 7809177
    [Abstract] [Full Text] [Related]

  • 9. Fibrates and HDL cholesterol.
    Murphy MJ, Packard CJ, O'Reilly DS.
    Ann Clin Biochem; 1997 Jan 01; 34 ( Pt 1)():114. PubMed ID: 9022900
    [No Abstract] [Full Text] [Related]

  • 10. [The action of a fibric acid derivative on lipid metabolism].
    Filip M, Păduraru I, Nechifor M, Dănilă GH, Popovici I, Filip FM, Poşircă F.
    Rev Med Chir Soc Med Nat Iasi; 1989 Jan 01; 93(3):573-6. PubMed ID: 2636755
    [Abstract] [Full Text] [Related]

  • 11. Effects of fibric acid derivatives on biliary lipid composition.
    Palmer RH.
    Am J Med; 1987 Nov 27; 83(5B):37-43. PubMed ID: 3318452
    [Abstract] [Full Text] [Related]

  • 12. Effect of fibric acid derivatives on blood lipid and lipoprotein levels.
    Hunninghake DB, Peters JR.
    Am J Med; 1987 Nov 27; 83(5B):44-9. PubMed ID: 3318453
    [Abstract] [Full Text] [Related]

  • 13. Effects of various fibrates on serum alkaline phosphatase activity.
    Ganotakis E, Tsimihodimos V, Bairaktari E, Rizos E, Athyros V, Seferiades C, Elisaf M.
    Atherosclerosis; 2002 Nov 27; 165(1):187-8. PubMed ID: 12208487
    [No Abstract] [Full Text] [Related]

  • 14. Fibrate-induced increase in blood urea and creatinine.
    Lipscombe J, Bargman JM.
    Nephrol Dial Transplant; 2001 Jul 27; 16(7):1515. PubMed ID: 11427661
    [No Abstract] [Full Text] [Related]

  • 15. Ciprofibrate and lipid profile.
    McLeod AJ, Warren RJ, Armitage M.
    Lancet; 1994 Oct 01; 344(8927):955. PubMed ID: 7934365
    [No Abstract] [Full Text] [Related]

  • 16. Transitory deficit in high-density lipoproteins and apolipoprotein A-I.
    Legras B, Clerc C, Ruelland A, Doualin G, Fertil V, Cloarec L.
    Clin Chem; 1990 Mar 01; 36(3):580-1. PubMed ID: 2107044
    [No Abstract] [Full Text] [Related]

  • 17. Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study.
    Mikhailidis DP, Jagroon IA.
    Metabolism; 2001 Nov 01; 50(11):1385-6. PubMed ID: 11715936
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of familial combined hyperlipidemia].
    Bruckert E.
    Ann Endocrinol (Paris); 1997 Nov 01; 58(4):297-301. PubMed ID: 9436478
    [No Abstract] [Full Text] [Related]

  • 19. [Antilipemic therapy in dyslipidemias in obese non-insulin-dependent diabetics (ONIDDM)].
    Palel G, Coman A, Petrovanu R, Ungureanu D, Cojocaru M.
    Rev Med Chir Soc Med Nat Iasi; 1997 Nov 01; 101(3-4):120-2. PubMed ID: 10756782
    [Abstract] [Full Text] [Related]

  • 20. The effects of fibrates on lipoprotein and hemostatic coronary risk factors.
    Schonfeld G.
    Atherosclerosis; 1994 Dec 01; 111(2):161-74. PubMed ID: 7718018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.